000 | 02189 a2200589 4500 | ||
---|---|---|---|
005 | 20250517104848.0 | ||
264 | 0 | _c20170809 | |
008 | 201708s 0 0 eng d | ||
022 | _a1178-2005 | ||
024 | 7 |
_a10.2147/COPD.S89923 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBhattacharya, Amal | |
245 | 0 | 0 |
_aEfficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. _h[electronic resource] |
260 |
_bInternational journal of chronic obstructive pulmonary disease _c2016 |
||
300 |
_a1469-76 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aAdrenergic beta-2 Receptor Agonists _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAerosol Propellants _xadverse effects |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForced Expiratory Volume |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocarbons, Fluorinated _xadverse effects |
650 | 0 | 4 | _aIndia |
650 | 0 | 4 |
_aIpratropium _xadministration & dosage |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetered Dose Inhalers |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTherapeutic Equivalency |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aBhargava, Salil | |
700 | 1 | _aSingh, Virendra | |
700 | 1 | _aTalwar, Deepak | |
700 | 1 | _aWhig, Jagdeep | |
700 | 1 | _aRebello, Juliet | |
700 | 1 | _aPurandare, Shrinivas | |
700 | 1 | _aGogtay, Jaideep | |
773 | 0 |
_tInternational journal of chronic obstructive pulmonary disease _gvol. 11 _gp. 1469-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/COPD.S89923 _zAvailable from publisher's website |
999 |
_c26230087 _d26230087 |